AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Collagen Solutions Plc, Product Pipeline Analysis, 2019 Update - Operations in the UK, US, South Korea & New Zealand - ResearchAndMarkets.com

January 20, 2020 GMT

DUBLIN--(BUSINESS WIRE)--Jan 20, 2020--

The “Collagen Solutions Plc (COS) - Product Pipeline Analysis, 2019 Update” company profile has been added to ResearchAndMarkets.com’s offering.

Summary

Collagen Solutions Plc (Collagen Solutions), formerly Healthcare Investment Opportunities Plc, is a medical device company that develops, manufactures and supplies medical grade collagen biomaterials and components. The company offers sourcing and supply of high grade collagen; provision of functional collagen bio-materials; and contract manufacture of collagen-based products and medical devices, among others. It provides bovine spongiform encephalopathy (BSE)-free bovine biomaterials to meet customer specifications including bone, cartilage and tendon, and veins and blood vessels. Collagen Solutions’ products are used in research, diagnostics, medical devices and regenerative medicine. The company offers product development and contract manufacturing services including technology transfer and regulatory support to pharmaceutical and medical device companies. It has operations in the UK, the US, South Korea and New Zealand. Collagen Solutions is headquartered in Glasgow, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

Reasons to Buy:

Key Topics Covered:

Companies Mentioned

For more information about this company profile visit https://www.researchandmarkets.com/r/xfkwrx

View source version on businesswire.com:https://www.businesswire.com/news/home/20200120005279/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH MEDICAL DEVICES

SOURCE: Research and Markets

Copyright Business Wire 2020.

PUB: 01/20/2020 08:51 AM/DISC: 01/20/2020 08:51 AM

http://www.businesswire.com/news/home/20200120005279/en